About Polly Mitchell

This author has not yet filled in any details.
So far Polly Mitchell has created 121 blog entries.

Immuno-Oncology Summit

August 27-31, 2018 | Boston, MA "Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs." - www.immuno-oncologysummit.com Learn more

By | 2018-07-13T14:57:28+00:00 July 5th, 2018|Categories: Upcoming Events|0 Comments

Brewing Summit 2018

August 12-15, 2018 | San Diego, CA "It's been a busy four years and we're excited to see you all in sunny San Diego for Brewing Summit 2018! Master Brewers and ASBC join forces to bring you the most extensive lineup of leaders in the beer brewing industry. Discover all the latest insights and innovations—with engineering insights, new developments in quality procedures, recipes to try, technical sessions, networking events, and more. Whether you're currently working as a craft brewer or just starting out in your field, there are plenty of opportunities to advance your scope of technical knowledge at Brewing Summit [...]

By | 2018-07-13T15:00:21+00:00 July 1st, 2018|Categories: Upcoming Events|0 Comments

Counting Brettanomyces is Complicated

If you use Brettanomyces in your brewery, you know that counting brett cells is complicated. Leo Chan joins MBAA to discuss the development of a method to automate cell counting of Brettanomyces. Check out the podcast here: https://goo.gl/pGT3vs

By | 2018-06-15T15:33:14+00:00 June 12th, 2018|Categories: Cellometer Application News, Latest News|0 Comments

Live Webinar: “Patients derived organoids (PDOs) to model therapy response ex vivo”

Join us on Thursday, June 7th for an informational webinar by Somaieh Hedayat of The Institute of Cancer Research. She will discuss different approaches to recapitulate the metastatic niche and compare PDOs drug responses observed in the laboratory ex vivo with clinical responses observed in patients and how those techniques will allow the study of PDO drug responses in the pre-clinical setting strengthening their value as a platform for drug screening, discovery and development. About Somaieh Hedayat: Somaieh Hedayat is working towards a PhD on how the tissue microenvironment can affect the response of metastatic colorectal cancer cells to antiangiogenic therapies. Prior [...]

By | 2018-06-14T19:46:01+00:00 May 30th, 2018|Categories: Upcoming Events|0 Comments

Poster: High-throughput immune complex analysis method for CAR T cell-mediated cytotoxicity using the Celigo Image Cytometer

Download our Poster Abstract: Cancer immunotherapy has been gaining momentum in the field of cancer research. Specifically, Chimeric Antigen Receptor (CAR) T cell technology have introduced new methods to combat cancer. Direct cell-mediated cytotoxicity assays are required to assess the killing capability of the engineered CAR T cells. Traditionally, these assays are conducted by measuring the amount of released Chromium, calcein AM, or LDH molecules after the target cancer cells are killed with CAR T cells. These methods require a large amount of target cells which may not be ideal when working with donor primary samples. Additionally, they cannot [...]

By | 2018-06-21T14:01:23+00:00 April 5th, 2018|Categories: Celigo Application News, Latest News|Tags: , , , |0 Comments

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

The latest news from Nexcelom Bioscience March 20, 2018 - Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners (PDF) March 20, 2018, Lawrence, MA -- Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.  The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative cellular analysis instruments, software and related consumables used in a broad range of research fields including immuno-oncology, cell therapy, drug discovery, [...]

By | 2018-06-05T17:29:56+00:00 March 20th, 2018|Categories: Company News|0 Comments